메뉴 건너뛰기




Volumn 24, Issue 2, 2011, Pages 357-366

Complement system and rheumatoid arthritis: Relationships with autoantibodies, serological, clinical features, and anti-TNF treatment

Author keywords

Autoantibodies; Complement; Disease activity; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; AUTOANTIBODY; C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOSPORIN; ETANERCEPT; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; PREDNICARBATE; PREDNISONE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR INHIBITOR; COMPLEMENT; COMPLEMENT CH50; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN FRAGMENT; PLASMA PROTEIN; SPLIT PRODUCT OF C3; UNCLASSIFIED DRUG; ANTIRHEUMATIC AGENT; BIOLOGICAL MARKER; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

EID: 80051751701     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400209     Document Type: Article
Times cited : (40)

References (27)
  • 1
    • 67349228199 scopus 로고    scopus 로고
    • Genetics of rheumatoid arthritis: Underlying evidence of ethnic differences
    • Kochi Y, Suzuki A, Yamada R, Yamamoto K. Genetics of rheumatoid arthritis: underlying evidence of ethnic differences. J Autoimmun 2009; 32:158-62.
    • (2009) J Autoimmun , vol.32 , pp. 158-162
    • Kochi, Y.1    Suzuki, A.2    Yamada, R.3    Yamamoto, K.4
  • 3
    • 33750817321 scopus 로고    scopus 로고
    • Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis
    • DOI 10.1016/j.autrev.2006.03.008, PII S1568997206000395
    • Van Venrooij WJ, Zendman AJW, Pruijn GJM. Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. Autoimmun Rev 2006; 6:37-41 (Pubitemid 44716772)
    • (2006) Autoimmunity Reviews , vol.6 , Issue.1 , pp. 37-41
    • Van Venrooij, W.J.1    Zendman, A.J.W.2    Pruijn, G.J.M.3
  • 4
    • 60349127531 scopus 로고    scopus 로고
    • Complement activation and inhibition: A delicate balance
    • Sjoberg AP, Trouw LA, Blom AM. Complement activation and inhibition: a delicate balance. Trends Immunol 2009; 30:83-90.
    • (2009) Trends Immunol , vol.30 , pp. 83-90
    • Sjoberg, A.P.1    Trouw, L.A.2    Blom, A.M.3
  • 6
    • 67650065027 scopus 로고    scopus 로고
    • Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways
    • Trouw LA, Haisma EM, Levarht EW, et al. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum 2009; 60:1923-31.
    • (2009) Arthritis Rheum , vol.60 , pp. 1923-1931
    • Trouw, L.A.1    Haisma, E.M.2    Levarht, E.W.3
  • 8
    • 5444231338 scopus 로고    scopus 로고
    • Remission in rheumatoid arthritis: Agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria
    • DOI 10.1093/rheumatology/keh297
    • Fransen J, Creemers MC, Van Riel PL. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford) 2004; 43:1252-5 (Pubitemid 39359299)
    • (2004) Rheumatology , vol.43 , Issue.10 , pp. 1252-1255
    • Fransen, J.1    Creemers, M.C.W.2    Van Riel, P.L.C.M.3
  • 9
    • 0030068817 scopus 로고    scopus 로고
    • Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria
    • DOI 10.1002/art.1780390105
    • Van Gestel AM, Prevoo ML, Van 't Hof MA, Van Rijswijk MH, Van de Putte LB, Van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996; 39:34-40. (Pubitemid 26036375)
    • (1996) Arthritis and Rheumatism , vol.39 , Issue.1 , pp. 34-40
    • Van Gestel, A.M.1    Prevoo, M.L.L.2    Van't, H.M.A.3    Van Rijswijk, M.H.4    Van De, P.L.B.A.5    Van Riel, P.L.C.M.6
  • 11
    • 4444225379 scopus 로고    scopus 로고
    • Hereditary and acquired angioedema: Problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
    • Agostoni A, Aygören-Pürsün E, Binkley KE, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004; 114:S51-131.
    • (2004) J Allergy Clin Immunol , vol.114
    • Agostoni, A.1    Aygören-Pürsün, E.2    Binkley, K.E.3
  • 13
    • 0022994184 scopus 로고
    • Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a
    • DOI 10.1002/art.1780291103
    • Watson WC, Cremer MA, Wooley PH, Townes AS. Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis: evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a. Arthritis Rheum 1986; 29:1316-21 (Pubitemid 17214031)
    • (1986) Arthritis and Rheumatism , vol.29 , Issue.11 , pp. 1316-1321
    • Watson, W.C.1    Cremer, M.A.2    Wooley, P.H.3    Townes, A.S.4
  • 14
    • 0026354378 scopus 로고
    • Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis
    • Brodeur JP, Ruddy S, Schwartz LB, Moxley G. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis. Arthritis Rheum 1991; 34:1531 -7.
    • (1991) Arthritis Rheum , vol.34 , pp. 1531-1537
    • Brodeur, J.P.1    Ruddy, S.2    Schwartz, L.B.3    Moxley, G.4
  • 15
    • 0023001135 scopus 로고
    • Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis
    • DOI 10.1002/art.1780291108
    • Mollnes TE, Paus A. Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis. Arthritis Rheum 1986; 29:1359-64. (Pubitemid 17214036)
    • (1986) Arthritis and Rheumatism , vol.29 , Issue.11 , pp. 1359-1364
    • Mollnes, T.E.1    Paus, A.2
  • 16
    • 33646368660 scopus 로고    scopus 로고
    • Evaluation of classical complement pathway activation in rheumatoid arthritis: Measurement of C1q-C4 complexes as novel activation products
    • DOI 10.1002/art.21729
    • Wouters D, Voskuyl AE, Molenaar ET, Dijkmans BA, Hack CE. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products. Arthritis Rheum 2006; 54:1143-50. (Pubitemid 43672927)
    • (2006) Arthritis and Rheumatism , vol.54 , Issue.4 , pp. 1143-1150
    • Wouters, D.1    Voskuyl, A.E.2    Molenaar, E.T.H.3    Dijkmans, B.A.C.4    Hack, C.E.5
  • 18
    • 0034052961 scopus 로고    scopus 로고
    • Evidence for activation of the alternate complement pathway in patients with juvenile rheumatoid arthritis
    • Aggarwal A, Bhardwaj A, Alam S, Misra R. Evidence for activation of the alternate complement pathway in patients with juvenile rheumatoid arthritis. Rheumatology (Oxford). 2000; 39:189-92. (Pubitemid 30139354)
    • (2000) Rheumatology , vol.39 , Issue.2 , pp. 189-192
    • Aggarwal, A.1    Bhardwaj, A.2    Alam, S.3    Misra, R.4
  • 22
    • 70449516048 scopus 로고    scopus 로고
    • Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
    • De Vries MK, Van Eijk IC, Van der Horst-Bruinsma IE, Peters MJ, Nurmohamed MT, Dijkmans BA, Hazenberg BP, Wolbink GJ. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis. Arthritis Rheum 2009; 61:1484-90.
    • (2009) Arthritis Rheum , vol.61 , pp. 1484-1490
    • De Vries, M.K.1    Van Eijk, I.C.2    Van Der Horst-Bruinsma, I.E.3    Peters, M.J.4    Nurmohamed, M.T.5    Dijkmans, B.A.6    Hazenberg, B.P.7    Wolbink, G.J.8
  • 23
    • 0025995227 scopus 로고
    • Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium: Quantitative analysis and effect of intraarticular corticosteroids
    • Firestein GS, Paine MM, Littman BH. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium: quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum 1991; 34:1094-105
    • (1991) Arthritis Rheum , vol.34 , pp. 1094-1105
    • Firestein, G.S.1    Paine, M.M.2    Littman, B.H.3
  • 24
    • 10344229927 scopus 로고    scopus 로고
    • Up regulation of C3, C4, and soluble intercellular adhesion molecule-1 co-expresses with high sensitivity C reactive protein in familial hypoalphalipoproteinaemia: Further evidence of inflammatory activation
    • DOI 10.1136/hrt.2003.017327
    • Sampietro T, Bigazzi F, Dal Pino B, et al. Up regulation of C3, C4, and soluble intercellular adhesion molecule-1 co-expresses with high sensitivity C reactive protein in familial hypoalpha lipoproteinaemia: further evidence of inflammatory activation. Heart 2004; 90:1438-42. (Pubitemid 39626321)
    • (2004) Heart , vol.90 , Issue.12 , pp. 1438-1442
    • Sampietro, T.1    Bigazzi, F.2    Dal, P.B.3    Rossi, G.4    Chella, E.5    Lusso, S.6    Puntoni, M.7    Tuoni, M.8    Bionda, A.9
  • 25
    • 8644277199 scopus 로고    scopus 로고
    • Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women
    • DOI 10.1016/j.atherosclerosis.2004.07.022, PII S0021915004003946
    • Széplaki G, Prohászka Z, Duba J, et al. Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. Atherosclerosis 2004; 177:383-9. (Pubitemid 39505272)
    • (2004) Atherosclerosis , vol.177 , Issue.2 , pp. 383-389
    • Szeplaki, G.1    Prohaszka, Z.2    Duba, J.3    Rugonfalvi-Kiss, S.4    Karadi, I.5    Kokai, M.6    Kramer, J.7    Fust, G.8    Kleiber, M.9    Romics, L.10    Varga, L.11
  • 26
    • 63749093322 scopus 로고    scopus 로고
    • Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
    • Kaymakcalan Z, Sakorafas P, Bose S, Scesney S, Xiong L, Hanzatian DK, Salfeld J, Sasso EH. Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor. Clin Immunol 2009; 131:308-16.
    • (2009) Clin Immunol , vol.131 , pp. 308-316
    • Kaymakcalan, Z.1    Sakorafas, P.2    Bose, S.3    Scesney, S.4    Xiong, L.5    Hanzatian, D.K.6    Salfeld, J.7    Sasso, E.H.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.